Oncternal Therapeutics, Inc. (ONCT) Balance Sheet Quarterly

Oncternal Therapeutics, Inc.

ONCT (NASDAQ)

(%)

Financials
Oncternal Therapeutics, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2024 (Q3) 09-30	2024 (Q2) 06-30	2024 (Q1) 03-31	2023 (Q4) 12-31	2023 (Q3) 09-30	2023 (Q2) 06-30	2023 (Q1) 03-31
Report Filing:	2024-11-06	2024-08-08	2024-05-09	2024-03-07	2023-11-09	2023-08-10	1234
Total Current Assets	15.45	23.26	28.5	36.06	42.49	50.08	1234
Cash and Short Term Investments	14.58	21.43	27.03	34.26	40.3	45.5	1234
Cash & Equivalents	13.08	6.38	6.4	6.7	14.93	15.83	1234
Short Term Investments	1.5	15.05	20.63	27.56	25.38	29.67	1234
Receivables	0.344	0.563	0.717	0.632	0	0	1234
Inventory	0	0	0	0	-0.186	0	1234
Other Current Assets	0.525	1.26	0.76	1.17	2.37	4.57	1234
Total Assets	15.6	23.86	29.14	36.73	43.2	50.77	1234
Total Non-Current Assets	0.154	0.602	0.637	0.67	0.703	0.698	1234
Property, Plant and Equipment	0.154	0.19	0.225	0.258	0.291	0.366	1234
Goodwill and Intangible Assets	0	0	0	0	0	0	1234
Goodwill	0	0	0	0	0	0	1234
Intangible Assets	0	0	0	0	0	0	1234
Long Term Investments	0	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	0	0.412	0.412	0.412	0.412	0.332	1234
Total Current Liabilities	6.45	8.05	6.12	5.2	5.15	4.83	1234
Accounts Payable	1.2	1.9	1.46	1.15	2.13	2.22	1234
Notes Payable/Short Term Debt	0.191	0.185	0.179	0.173	0.302	0.29	1234
Tax Payables	0	0	0	0	0	0	1234
Deferred Revenue	0	0	0	0	0	0	1234
Other Current Liabilities	5.06	5.97	4.47	3.88	2.72	2.32	1234
Total Liabilities	6.45	8.11	6.21	6.68	6.2	5.59	1234
Total Non-Current Liabilities	0	0.05	0.099	1.48	1.05	0.758	1234
Total Long Term Debt	0	0.05	0.099	0.145	0.191	0.221	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0	0	0	0	0	1234
Capital Lease Obligations	0.191	0.235	0.278	0.318	0.342	0.366	1234
Other Long Term Liabilities	-0.191	-0.235	-0.278	1.02	0.514	0.171	1234
Total Equity	9.15	15.75	22.93	30.05	-188.6	-178.8	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	9.15	15.75	22.93	30.05	-188.6	-178.8	1234
Retained Earnings	-223.2	-214.7	-206.2	-197.8	-188.6	-178.8	1234
Accumulated Other Earnings	0.001	-0.003	-0.008	0.003	0	-0.006	1234
Common Stock	0.003	0.003	0.003	0.003	0.059	0.059	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	232.3	230.5	229.1	227.8	225.6	223.9	1234
Total Liabilities & Total Equity	15.6	23.86	29.14	36.73	-182.4	-173.2	1234
Total Liabilities & Shareholders' Equity	15.6	23.86	29.14	36.73	43.2	50.77	1234
Total Investments	1.5	15.05	20.63	27.56	25.38	29.67	1234
Total Debt	0.191	0.235	0.278	0.318	0.342	0.366	1234
Net Debt	-12.89	-6.15	-6.12	-6.38	-14.58	-15.47	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Oncternal Therapeutics, Inc. Balance Sheet Statement Quarterly